What is Juvenile Mitral Stenosis
Juvenile mitral stenosis (JMS) is mitral stenosis detected in patients below 20 years of age, most commonly caused by rheumatic heart disease, and represents 25-40% of all isolated mitral stenosis cases. 1
Definition and Etiology
JMS is distinguished from adult mitral stenosis primarily by the age of presentation rather than fundamental pathophysiology. The condition is predominantly rheumatic in origin, resulting from acute rheumatic fever that leads to progressive valvular damage. 1 The pathologic process involves:
- Thickened mitral leaflets with fused commissures (rheumatic variant)
- Shortened chordae tendineae and decreased interchordal spaces
- Progressive fibrosis and calcification over time
Important distinction: While rheumatic disease is the predominant cause, congenital mitral stenosis must be differentiated in this age group, as it encompasses distinct anatomic variants including supramitral rings, double mitral orifices, parachute mitral valve, and hypoplastic mitral valve. 2 These congenital variants respond differently to intervention and are frequently associated with other congenital cardiac defects (84-97% of cases). 3
Clinical Presentation
Symptoms in infants and young children differ markedly from adults and may be limited to:
Unlike adults who present with classic New York Heart Association functional class symptoms, pediatric patients often present with more subtle signs that require high clinical suspicion.
Diagnostic Criteria
Hemodynamic Parameters for Moderate-to-Severe Disease:
Based on the largest pediatric series, significant JMS warranting intervention typically demonstrates: 2
- Peak transmitral gradient: ≥20 mmHg
- Mean transmitral gradient: ≥15 mmHg
- Mitral valve area: ≤1.0 cm²/m²
- Left atrial pressure: ≥24 mmHg
- Pulmonary artery pressure: Near-systemic levels (mid-40s mmHg mean)
Echocardiographic Findings:
- Mitral valve area <1.5 cm² defines clinically significant stenosis 4
- Severe stenosis: MVA ≤1.0 cm² 5
- Associated findings include left atrial enlargement and elevated pulmonary artery systolic pressure
Key Diagnostic Pitfall
The second-most-common cause of mitral stenosis in young patients is congenital mitral stenosis, which must be differentiated from rheumatic disease. 3 Congenital variants are readily identified by:
- Abnormal papillary muscle arrangements
- Associated congenital cardiac defects (present in 84-97% of cases)
- Absence of rheumatic morphologic features (commissural fusion pattern)
Worldwide, rheumatic disease still accounts for 95-99.3% of all mitral stenosis in individuals <50 years of age. 3
Clinical Significance
JMS carries high surgical mortality and morbidity in infants and young children, making accurate diagnosis and appropriate intervention timing critical. 2 The condition can progress rapidly, leading to:
- Severe pulmonary hypertension
- Heart failure
- Systemic embolization risk
- Growth failure
Prognosis varies significantly based on etiology: Rheumatic JMS with commissural fusion responds favorably to percutaneous balloon valvuloplasty (87.7% success rate), 6 while congenital variants with parachute valves, supramitral rings, or small mitral annulus have worse outcomes. 2